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Edited by Stuart FergusonAbstract The mazEF (chpA) toxin–antitoxin system of Esch-
erichia coli is involved in the cell response to nutritional and
antibiotic stresses as well as in bacterial-programmed cell death.
Valuable information on the MazF toxin was derived from the
determination of the crystal structure of the MazE/MazF
complex and from in vivo data, suggesting that MazF promoted
ribosome-dependent cleavage of messenger RNA. However, it
was concluded from recent in vitro analyses using a MazF-(His6)
fusion protein that MazF was an endoribonuclease that cleaved
messenger RNA speciﬁcally at 50-ACA-30 sites situated in single-
stranded regions. In contrast, our work reported here shows that
native MazF protein cleaves RNA at the 50 side of residue A in
50-NAC-30 sequences (where N is preferentially U or A). MazF-
dependent cleavage occurred at target sequences situated either
in single- or double-stranded RNA regions. These activities were
neutralized by a His6-MazE antitoxin. Although essentially
consistent with previous in vivo reports on the substrate
speciﬁcity of MazF, our results strongly suggest that the
endoribonuclease activity of MazF may be modulated by
additional factors to cleave messenger and other cellular RNAs.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Toxin–antitoxin (TA) systems are found in bacterial chro-
mosomes and plasmids as well as in archaeal genomes [1–3].
They usually consist of two genes, arranged as an operon, that
encode a toxin and its cognate antitoxin, respectively [2,4].
Plasmid-borne TA systems contribute to plasmid maintenance
by preventing the growth of plasmid-free progeny, through a
mechanism called post-segregational killing [5,6]. Less clear is* Corresponding author. Fax: +34-91-536-0432.
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doi:10.1016/j.febslet.2004.05.005the biological role of chromosomal TA systems. A major
source of information came from the studies on the mazEF
system (also called chpA) of Escherichia coli [7]. This system is
homologous to the identical parD and pem systems found,
respectively, in plasmids R1 and R100 [8,9]. mazEF is com-
posed of two adjacent genes, mazE and mazF, that are located
downstream of the relA gene [10]. MazF is a stable toxin, while
MazE is a labile antitoxin degraded by the ClpPA serine
protease. MazF binds to MazE and this interaction protects
the cells against the toxicity of MazF [11]. The recently solved
crystal structure of the MazE/MazF complex revealed that
both proteins form a linear heterohexamer composed of al-
ternating toxin and antidote homodimers (MazF2–MazE2–
MazF2). Within this complex, the interactions between MazE
and MazF are primarily mediated by the C-terminal portion of
MazE [12]. In addition, the combined action of MazE and
MazF is required to eﬃciently autoregulate the mazEF operon
at the transcriptional level [11,13]. Furthermore, the mazEF
system was shown to mediate cell death following thymine
starvation or exposure to antibiotics or toxins that inhibit
transcription and/or translation [14–16]. On the other hand,
overproduction of MazF in E. coli was shown to inhibit pro-
tein synthesis and DNA replication in vivo leading to the ar-
rest of cell growth, all these eﬀects being reversed by the later
expression of the MazE antitoxin gene [17]. Moreover, the
mechanism of action of the MazF toxin has been approached
by two recent reports. The ﬁrst one indicated that the in vivo
overproduction of the MazF toxin induced the cleavage of
translated mRNAs [18], thus closely resembling the mechanism
of RelE, the toxin of the TA system relBE of E. coli that
catalyzes the cleavage of speciﬁc mRNA codons at the A site
of the ribosome [19,20]. The second piece of work, which was
carried out in vitro using a puriﬁed histidine-tagged MazF
protein (MazF-His6), indicated that this toxin was an endo-
ribonuclease that cleaved only single-stranded RNA regions
speciﬁcally at ACA sequences [21]. In essence, these reports
were consistent in that MazF mediates messenger RNA
cleavage to cause a block of protein synthesis in vivo. How-
ever, the ﬁnding of a ribosome-independent ribonuclease ac-
tivity [21] argued against the claim that MazF cleavage
exclusively involved mRNA molecules that were being trans-
lated [18]. Moreover, the RNA cleavage speciﬁcities reported
in vivo for MazF [18] and in vitro for His6-MazF [21] were
basically inconsistent. Here, we aimed to clarify the situation
by carrying out an independent in vitro analysis of MazFblished by Elsevier B.V. All rights reserved.
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studies in that we use: (i) a preparation of native MazF protein
whose quality is supported by biophysical and functional evi-
dence; (ii) a set of well-characterized natural RNA substrates;
and (iii) a direct technique that allows the visualization of all
the cleavage products for a given substrate. Our results show
that MazF cleaves single- and double-stranded RNA at the 50
side of residue A in 50-NAC-30 sequences (where N is prefer-
entially U or A). These data are discussed in the light of the
available information on the biological function of MazF.2. Materials and methods
2.1. Protein puriﬁcation
The MazF toxin and the His6-tagged MazE antitoxin were puriﬁed
following a protocol identical to the one that was formerly used to purify
the Kid and His6-Kis proteins [22]. The proteins were diluted in 0 mM
KCl, 20 mMHEPES-KOH pH 7.8, and 100 lgml1 BSA before use.
2.2. Biophysical experiments
Sedimentation equilibrium experiments were performed with MazF
at 45 lM in 100 mM sodium phosphate buﬀer, pH 7.0, as described
[23]. Circular dichroism spectroscopy (CD) and thermal denaturation
studies were carried out with MazF at 15 lM in the same buﬀer, as
described [23].
2.3. Antitoxin–toxin interaction
The His6-MazE antitoxin (50 lg in 200 mM KCl and 20 mM im-
idazole, pH 8.0) was incubated with nickel-activated Sepharose beads
(Amersham Biosciences) for 1 h at 4 C, using an orbital shaker. The
beads were then recovered by centrifugation at 13 000 rpm for 1 min at
4 C in a bench centrifuge (Eppendorf) and the supernatant was dis-
carded. To wash unbound His6-MazE, the beads were resuspended in
500 ll binding buﬀer and incubated at 4 C with gentle shaking for 30
min. The beads were collected by centrifugation as above and were
resuspended in 200 ll of buﬀer containing the MazF toxin (50 lg). The
suspension was further incubated at 4 C for 1 h with orbital shaking.
Then, the beads were separated from the supernatant by centrifugation
and the supernatant (S sample) was kept at 4 C. The beads were
washed extensively by repeating three times the washing step described
above and were collected by centrifugation (P sample). The S and P
samples were brought to the same volume of buﬀer and identical
volumes were analyzed by SDS–PAGE (15%). The proteins in the gel
were visualized by Coomassie blue staining.
2.4. Inhibition of protein synthesis in rabbit reticulocyte lysates
Reaction mixtures (10 ll) contained the components from the
Rabbit Reticulocyte Lysate System (Promega): 7 ll of rabbit reticu-
locyte lysate, 0.2 ll of amino-acid mixture minus methionine (1 mM),
0.1 lg of luciferase control RNA, and 0.3 ll of KCl (70 mM, ﬁnal
concentration) complemented with 0.2 ll of RNAguard Ribonuclease
Inhibitor (Amersham Biosciences). The assays were started by adding
4 lCi of [35S]methionine and the MazF and/or His6-MazE proteins
and were incubated for 1 h at 37 C. The reactions were analyzed using
SDS–PAGE (10%).
2.5. In vitro RNA cleavage analysis
TAR, CopA, and CopT RNAs were obtained from in vitro tran-
scription with T7 RNA polymerase using as DNA templates: the
pG3TAR plasmid [24] linearized with HindIII, for TAR RNA; PCR
products derived from the pGW644 vector [25] using the pairs of
primers 50-TAATACGACTCACTATAGGCATAGCTGAATTGTT-
GG-30=50 GCCAGAAAAGCAAAAACC-30 and 50-TAATACGACT-
CACTATAGGCCAGAAAAGCAAAAACC-30=50-GCATAGCTG-
AATTGTTGG-30 for CopA and CopT RNAs, respectively. The
RNAs were 50-end-labelled with [c-32P]ATP as described [26] and were
separated on a 6% polyacrylamide gel containing 7 M Urea in TBE
buﬀer. In vitro cleavage reactions were carried out with 1000 cpm of 50-
end-labelled RNAs in 10 mM KCl, 10 lgml1BSA, and 2 mM HE-
PES, pH 7.8, in the presence of 4 units of SUPERase-In (Ambion). Thepuriﬁed MazF and His6-MazE proteins (1 ll) were added when ap-
propriate and the reactions were incubated for 2 min at 37 C. The
reactions were stopped by adding formamide loading buﬀer and
chilling quickly in dry ice. The RNAs were separated on a 8% poly-
acrylamide gel containing 7 M Urea in TBE buﬀer. The alkali ladder
was prepared just before loading by incubation of 4000 cpm end-la-
belled RNA with 1 lg tRNA in 50 mM NaHCO3/Na2CO3, pH 9.5, at
95 C for 90 s. Digestions with RNaseT1 were performed using
2000 cpm RNA, 1 lg tRNA, 1 unit of RNaseT1 (Ambion) in 100 mM
NaCl, 10 mMMg-acetate, and 20 mM Tris, pH 7.5, and incubating for
5 min at 37 C.3. Results and discussion
3.1. Biophysical and functional validation of the MazF
preparation
The native MazF protein was puriﬁed (Section 2.1) and
subsequently tested in a series of biophysical and functional
assays. Analysis of the association state of MazF by means of
sedimentation equilibrium indicated that, at a 45 lM con-
centration, the protein formed a complex of Mw;a  24000 Da
(Fig. 1A). This molecular mass corresponds essentially to a
dimer of MazF (Mw ¼ 24196 Da). The low dispersion of the
data and their adjustment to the theoretical curve expected for
an ideal dimer were consistent with previous reports [27] and
demonstrated that the sample was homogeneous at the tested
concentration. In addition, the average secondary structure of
MazF was analyzed by means of CD. The CD spectrum of the
MazF preparation (Fig. 1B) is dominated by the a-helicoidal
component (minimal values at 208 and 222 nm). Deconvolu-
tion analysis using the CDNN program predicted a contribu-
tion of the a-helicoidal component close to 23% and a higher
percentage of b-strand and b-turn elements which represent up
to 34% of the structure. The thermal stability of the protein,
tested in the range 5–90 C, indicated a co-operative transition
to the denatured state at a Tm of 48 C (Fig. 1C). Thus, both
the well-deﬁned CD spectrum and the co-operative transition
to the denatured state of the sample indicated a well-structured
and homogeneous protein preparation.
Next, we evaluated the activity of the puriﬁed MazF and
His6-MazE proteins in two functional assays. First, the in-
teraction between both proteins was tested by monitoring the
speciﬁc retention of MazF by nickel-activated Sepharose beads
bound to the His6-MazE antitoxin (Section 2.4). The result of
this analysis indicated that indeed the MazF and His6-MazE
proteins were able to tightly interact, since they formed a
complex that resisted high-salt washing (Fig. 2A). In a second
assay, we monitored the capacity of the MazF toxin to inhibit
protein synthesis in rabbit reticulocyte lysates, an activity that
has been reported [21]. This assay allows the visualization of
the products of translation of a puriﬁed mRNA encoding the
ﬁreﬂy luciferase (Section 2.5). Fig. 2B shows that the MazF
toxin dramatically inhibited protein synthesis in these extracts,
while preincubation of the assay with both MazF and His6-
MazE at a 1:1 molar ratio completely neutralized this inhibi-
tion. It should be noted that former studies performed with a
MazF-His6 protein tagged at the C-terminal end showed only
partial recovery of protein synthesis upon incubation with
excess His6-MazE antitoxin [21]. This suggests that a histidine-
tag situated at the C-terminal portion of MazF may interfere
with the functional interactions between this toxin and its
cognate antitoxin. Taken together, our results demonstrate
Fig. 1. Biophysical characterization of the MazF preparation. (A)
Analytical centrifugation at equilibrium. Lower panel: sedimenta-
tion equilibrium gradients obtained with 45 lM MazF at 19 000
rpm, 20 C in 100 mM sodium phosphate buﬀer. The solid line
represents the best ﬁt of the experimental data to a single ideal
dimeric species (Mw ¼ 24196 Da). Dashed lines correspond to the
theoretical ﬁt to monomer (Mw ¼ 12098 Da) and trimer
(Mw ¼ 36294 Da). The residuals of the ﬁt are shown in the upper
panel. (B) Circular dichroism spectrum and (C) thermal denatur-
ation proﬁle of the MazF toxin (15 lM) in 100 mM sodium
phosphate, pH 7.0.
Fig. 2. Functional assays using MazF. (A) Antitoxin–toxin interaction.
The His6-MazE protein (50 lg) bound to nickel-activated Sepharose
beads was incubated with the MazF protein (50 lg) as described in
Section 2. The beads were separated from the supernatant (S sample)
by centrifugation and were ﬁnally collected after extensive washing (P
sample). The S and P samples were analyzed by SDS–PAGE (15%). 1,
MazF toxin incubated with nickel-activated Sepharose beads in the
absence of His6-MazE; 2, MazF toxin incubated with nickel-activated
Sepharose beads bound to the His6-MazE antitoxin. The leftmost lane
is the Protein Molecular Weight Marker Broad Range (New England
Biolabs). The bands corresponding to Mw (kDa) 6.5, 14.3, and 20.1 are
indicated. (B) Protein synthesis in rabbit reticulocyte lysates using lu-
ciferase mRNA as template (see Section 2). 35S-labelled protein
products were analyzed using SDS–PAGE (10%). When indicated, the
reactions were incubated with MazF or His6-MazE, each at 0.3 lM.
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study were well folded and fully active.
3.2. RNA cleavage assays
MazF and His6-MazE were tested in RNA cleavage assays
using a panel of three small model RNA molecules that have
been extensively characterized at the structural and functional
levels, and that possess signiﬁcant diﬀerences in their primary
and secondary structures: the HIV-1 trans-activation response
element TAR [28], the CopA antisense RNA and its target
RNA CopT of plasmid R1 [29]. The three RNAs were 50-end-
labelled with 32P, puriﬁed, and challenged with increasing
amounts of the puriﬁed MazF toxin prior to being fractionated
by electrophoresis. RNA samples treated either with alkali or
with RNAseT1 were also included to allow the precise map-
ping of the cleavage sites. TAR, CopA, and CopT were cleaved
by the MazF toxin at three, two, and seven diﬀerent sites, re-
spectively (Fig. 3A and B). Cleavage was not observed when
MazF was provided together with the His6-MazE antitoxin,
thus indicating that the activity was speciﬁc. Analysis of the
RNA sequences around the cleavage sites showed that MazF
always cleaved at the 50 end of 50-AC-30 sequences (Fig. 3B and
C). The nucleotides situated at the 50 of the cleavage sites were,
in 10 out of 12 cases, A or U. In contrast, there was no sig-
niﬁcant conservation of the residue immediately at 30 of the
target 50-AC-30 sequence (Fig. 3C). Interestingly, the cleavage
sites were predominantly, but not always, situated in single-
stranded RNA regions (Fig. 3B). For example, the two copies
of 50-AAC-30 present in TAR (ﬁlled square and circle, Fig. 3B)
were cleaved by MazF, albeit being located in single- and
double-stranded regions, respectively (the same occurred with
the two 50-UAC-30 sites in CopT). However, inasmuch as
the intensities of the bands visualized in Fig. 3A reﬂect the
Fig. 3. In vitro RNA cleavage by MazF. (A) 50-32P-labelled RNAs TAR, CopA, and CopT were incubated with increasing amounts (0.005, 0.05, 0.5,
and 1 lM, respectively) of MazF protein prior to being fractionated by electrophoresis. Where indicated, MazE was added with MazF (1 lM each).
MazF cleavage sites are indicated by solid symbols. -, OH and T1 denote samples that were non-treated, partially hydrolyzed with alkali and digested
with RNase T1, respectively. (B) Secondary structures of TAR, CopA, and CopT RNAs and their respective MazF cleavage sites. Symbols are as
indicated in panel A. (C) A summary of the MazF cleavage sites and their neighboring RNA sequences.
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MazF, the sequences located in single-stranded regions seemed
to be ﬁrst-choice sites for MazF. Therefore, from this study it
can be concluded that MazF cleaves single- and double-
stranded RNA with a marked preference for 50-(U/A)AC-30
sequences in single-stranded RNA. Our ﬁndings are basically
consistent with the previous report of the in vitro endoribo-
nuclease activity of MazF by Zhang et al. [21]. However, these
authors claim that MazF cleaves mRNA speciﬁcally at 50-
ACA-30 sequences only in single-stranded regions. Our present
results do not support these conclusions. In contrast, three
lines of evidence argue in favor of our observations: (i) all the
50-(U/A)AC-30 sites present in TAR, CopA or CopT RNAs
were cut by MazF, with no exception (this work; Fig. 3B); (ii)
50-AAC-30 present in the E. coli tmRNA was a strong cleavage
site for MazF in vivo [18]; and (iii) although presented as an
exception rather than a rule, Zhang et al. [21] also show that
the lacZ mRNA is cleaved by MazF between the U and A
residues in a 50-UAC-30 site. However, the reasons for the
discrepancy between the work reported here and that of Zhang
and co-workers are unclear. As mentioned above, we use the
native MazF toxin in our RNA cleavage assays, while these
authors used a toxin with a histidine-tag at its C-terminal end
[21]. However, while this C-terminal extension could poten-
tially aﬀect the binding of MazF to its natural RNA target, or
to its cognate antitoxin (see Section 3.1), one would expect a
disruption of the endoribonuclease activity rather that the
acquisition of a new substrate speciﬁcity. Probably, the en-
doribonuclease activity of MazF is subject to subtle modula-
tion by additional factors, i.e., the sequence environment and/
or the secondary-structure of its RNA target. In this respect,
the technique that we use to monitor RNA cleavage is specially
adapted inasmuch as we visualize all the possible cleavage
products for a speciﬁc RNA substrate, thus leading to a more
comprehensive view of the ribonuclease activity of MazF. In
particular, our results demonstrate that MazF also cleaves
sequences that are situated in double-stranded RNA regions.
At present we do not know whether this results from the local
melting of RNA upon binding of MazF to distal sequences,
that then permits subsequent cleavage, or whether MazF ac-
tually binds double-stranded RNA and speciﬁcally cleaves the
target strand. Certainly, addressing this issue will beneﬁt from
the future resolution of MazF/RNA complexes at the struc-
tural level.
Moreover, in vivo experiments carried out by overexpressing
the nativemazF gene indicated that the RNA cleavage byMazF
occurs not only at 50-NAC-30 sites [18,21], thus further sup-
porting our view that the intrinsic activity of MazF is subject to
additional controls. Possibly, the in vivo function of MazF is
determined by its interaction with particular host factors (e.g.,
components of the translation machinery) in response to spe-
ciﬁc physiological stimuli, as previously suggested [18]. How-
ever, the relaxed substrate speciﬁcity of MazF and the fact that
cleavage occurs in a ribosome-independent manner suggest that
the ribonuclease activity of MazF may not be restricted to
targeting messenger RNA, but rather involves the regulation of
a larger panel of RNA-dependent cellular processes. Our group
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